Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Shares Issued (2018 - 2024)

Q32 Bio (QTTB) has 7 years of Shares Issued data on record, last reported at $40.6 million in Q4 2024.

  • For Q4 2024, Shares Issued rose 135510.0% year-over-year to $40.6 million; the TTM value through Sep 2025 reached $40.6 million, up 2915.81%, while the annual FY2024 figure was $42.0 million, N/A changed from the prior year.
  • Shares Issued reached $40.6 million in Q4 2024 per QTTB's latest filing, up from -$40.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $42.0 million in Q1 2024 and bottomed at -$40.6 million in Q3 2024.
  • Average Shares Issued over 5 years is $2.9 million, with a median of $439000.0 recorded in 2022.
  • The widest YoY moves for Shares Issued: up 135510.0% in 2024, down 135510.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $787000.0 in 2020, then plummeted by 186.4% to -$680000.0 in 2021, then soared by 187.35% to $594000.0 in 2022, then plummeted by 105.05% to -$30000.0 in 2023, then surged by 135510.0% to $40.6 million in 2024.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $40.6 million in Q4 2024, -$40.6 million in Q3 2024, and $42.0 million in Q1 2024.